These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24696941)

  • 1. Corporate social responsibility and hospitals: US theory, Japanese experiences, and lessons for other countries.
    Takahashi T; Ellen M; Brown A
    Healthc Manage Forum; 2013; 26(4):176-83. PubMed ID: 24696941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational rationality, performance, and social responsibility: results from the hospital industry.
    Becker ER; Potter SJ
    J Health Care Finance; 2002; 29(1):23-48. PubMed ID: 12199493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What CFOs should know--and do--about corporate responsibility.
    Peregrine MW; Schwartz JR
    Healthc Financ Manage; 2002 Dec; 56(12):60-3. PubMed ID: 12516161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of corporate restructuring on hospital policymaking.
    Alexander JA; Morlock LL; Gifford BD
    Health Serv Res; 1988 Jun; 23(2):311-37. PubMed ID: 3384671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New standards for corporate governance and the role of corporate counsel.
    Siegel S
    Health Care Law Mon; 2003 Jul; ():3-15. PubMed ID: 12931344
    [No Abstract]   [Full Text] [Related]  

  • 6. From corporate governance to hospital governance. Authority, transparency and accountability of Belgian non-profit hospitals' board and management.
    Eeckloo K; Van Herck G; Van Hulle C; Vleugels A
    Health Policy; 2004 Apr; 68(1):1-15. PubMed ID: 15033548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doing Good Again? A Multilevel Institutional Perspective on Corporate Environmental Responsibility and Philanthropic Strategy.
    Liu W; Wei Q; Huang SQ; Tsai SB
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29064451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy and society: the link between competitive advantage and corporate social responsibility.
    Porter ME; Kramer MR
    Harv Bus Rev; 2006 Dec; 84(12):78-92, 163. PubMed ID: 17183795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational safety and health aspects of corporate social responsibility (CSR) in Japanese companies listed on the Tokyo Stock Exchange (TSE) first section.
    Kawashita F; Taniyama Y; Hwi SY; Fujisaki T; Kameda T; Mori K
    J Occup Health; 2005 Nov; 47(6):533-9. PubMed ID: 16369117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of industry responsibility and tobacco control policy by US tobacco company executives in trial testimony.
    Chaiton M; Ferrence R; LeGresley E
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv98-106. PubMed ID: 17130631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corporate Social Responsibility Amid Social Distancing During the COVID-19 Crisis: BRICS vs. OECD Countries.
    Popkova E; DeLo P; Sergi BS
    Res Int Bus Finance; 2021 Jan; 55():101315. PubMed ID: 34173410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corporate social responsibility challenge on financial performance: Portuguese business situation.
    Carvalho C; Madaleno M
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):42965-42982. PubMed ID: 35199266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The path to corporate responsibility.
    Zadek S
    Harv Bus Rev; 2004 Dec; 82(12):125-32, 150. PubMed ID: 15605571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonprofit health systems: a promising new class of corporate citizen.
    Longest BB
    Inquiry; 2002-2003 Winter; 39(4):334-40. PubMed ID: 12638709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Corporate Social Responsibility and Public Attention on Innovation Performance: Evidence from High-polluting Industries.
    Wang W; Zhao XZ; Chen FW; Wu CH; Tsai S; Wang J
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking the prudent path. Best practices for not-for-profit boards.
    Peregrine MW; Schwartz JR
    Trustee; 2003; 56(10):24-7, 1. PubMed ID: 14650270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corporate social responsibility in the centers of the public hospital network of Catalonia (Spain)].
    Rodríguez Cala A; Calle Rodríguez C; Durán García N; Zöller B; Pons Rodríguez A
    Gac Sanit; 2021; 35(1):67-71. PubMed ID: 31447057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational Strategy and Corporate Social Responsibility: The Mediating Effect of Triple Bottom Line.
    Masud MAK; Rashid MHU; Khan T; Bae SM; Kim JD
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31752161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health insurance and corporate social responsibility.
    Carter T
    J Hosp Mark Public Relations; 2009; 19(1):64-86. PubMed ID: 19197657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging the power of the proxy. Catholic health care systems are using stock holdings to push for corporate accountability.
    Henzlik J; Fallender S
    Health Prog; 2003; 84(4):36-9. PubMed ID: 12905931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.